Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression

The role of protein kinase C (PKC) in in vitro invasiveness of four different human renal cell carcinoma (RCC) cell lines of the clear cell type was investigated. Different PKC-inhibitors markedly inhibited invasiveness of the highly invasive cell lines, suggesting an invasion-promoting role of PKC in human RCC. Analysis of PKC-isoenzyme expression by protein fractionation and immunoblotting revealed that all cell lines expressed PKC-α, -ɛ, -ζ, -μ and -ι as known from normal kidney tissue. Interestingly, PKC-δ, known to be expressed by normal kidney epithelial cells of the rat, was absent on protein and RNA levels in all RCC cell lines investigated and in normal human kidney epithelial cells. PKC-ɛ expression levels correlated positively with a high proliferation activity, but no obvious correlation between expression levels of distinct PKC-isoenzymes and in vitro invasiveness was observed. However, by immunofluorescence microscopy, membrane localisation of PKC-α and PKC-ɛ reflecting activation of the enzymes, was associated with a highly invasive potential. In conclusion, our results suggest a role for PKC in invasion of human RCCs and might argue in favour of a particular role of PKC-α and PKC-ɛ. Our results further suggest that organ-specific expression patterns of PKC-isoenzymes are not necessarily conserved during evolution. © 2000 Cancer Research Campaign

[1]  C. Gerharz,et al.  In vitro invasiveness of human epithelioid‐sarcoma cell lines: Association with cell motility and inverse correlation with the expression of tissue inhibitor of metalloproteinases , 1999, International journal of cancer.

[2]  R. Figlin,et al.  Renal cell carcinoma: recent progress and future directions. , 1997, Cancer research.

[3]  J. Prestle,et al.  Protein kinase C mu is located at the Golgi compartment , 1996, The Journal of cell biology.

[4]  S. Jaken Protein kinase C isozymes and substrates. , 1996, Current opinion in cell biology.

[5]  Q. Duh,et al.  Tamoxifen antagonizes proliferation and invasion of estrogen receptor-negative metastatic follicular thyroid cancer cells via protein kinase C. , 1996, Cancer letters.

[6]  Jun-Ping Liu Protein kinase C and its substrates , 1996, Molecular and Cellular Endocrinology.

[7]  P. McCue,et al.  Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. , 1995, Cancer research.

[8]  A. Cacace,et al.  Overexpression of protein kinase C β1 in the SW480 colon cancer cell line growth suppression , 1995 .

[9]  W. Kolch,et al.  Immunocytochemical Localization of Eight Protein Kinase C Isozymes Overexpressed in NIH 3T3 Fibroblasts , 1995, The Journal of Biological Chemistry.

[10]  A. Gescher,et al.  Differential inhibition of cytosolic and membrane‐derived protein kinase C activity by staurosporine and other kinase inhibitors , 1995, FEBS letters.

[11]  P. Parker,et al.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. , 1995, The Journal of clinical investigation.

[12]  P. Parker,et al.  Differential localization of protein kinase C isozymes in U937 cells: evidence for distinct isozyme functions during monocyte differentiation. , 1995, Journal of cell science.

[13]  K. Buchner Protein kinase C in the transduction of signals toward and within the cell nucleus. , 1995, European journal of biochemistry.

[14]  M. Ueffing,et al.  Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts , 1995, The Journal of Biological Chemistry.

[15]  R. Moll,et al.  Interclonal heterogeneity in a human epithelioid‐sarcoma cell line (Gru‐1) , 1994, International journal of cancer.

[16]  D. Fabbro,et al.  Protein kinase C isozyme expression and down-modulation in growing, quiescent, and transformed renal proximal tubule epithelial cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[17]  C. Arteaga,et al.  Distinct responses of protein kinase C isozymes to c-erbB-2 activation in SKBR-3 human breast carcinoma cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[18]  S. Stabnel Protein kinase C--an enzyme and its relatives. , 1994, Seminars in cancer biology.

[19]  F. Zunino,et al.  Effect of protein kinase C inhibitors on invasiveness of human melanoma clones expressing different levels of protein kinase C isoenzymes , 1994, International journal of cancer.

[20]  D. Fabbro,et al.  Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  J. Prestle,et al.  PKCu is a novel, atypical member of the protein kinase C family. , 1994, The Journal of biological chemistry.

[22]  C. Schmitz‐Peiffer,et al.  Molecular cloning and characterization of PKC iota, an atypical isoform of protein kinase C derived from insulin-secreting cells. , 1993, The Journal of biological chemistry.

[23]  L. Dong,et al.  Transformation-sensitive localization of alpha-protein kinase C at cell-cell contacts in rat renal proximal tubule epithelial cells. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  D. Fabbro,et al.  The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. , 1993, Oncogene.

[25]  G. Schwartz,et al.  Protein kinase C: a novel target for inhibiting gastric cancer cell invasion. , 1993, Journal of the National Cancer Institute.

[26]  S. Störkel,et al.  Ultrastructural appearance and cytoskeletal architecture of the clear, chromophilic, and chromophobe types of human renal cell carcinoma in vitro. , 1993, The American journal of pathology.

[27]  W. Wetsel,et al.  Tissue and cellular distribution of the extended family of protein kinase C isoenzymes , 1992, The Journal of cell biology.

[28]  H. Coste,et al.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.

[29]  G. H. Weiss,et al.  Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. , 1991, Cancer research.

[30]  Y. Nakamura,et al.  Allelotype of renal cell carcinoma. , 1991, Cancer research.

[31]  D. Fabbro,et al.  A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and In vitro anti‐proliferative as well as In vivo anti‐tumor activity , 1989, International journal of cancer.

[32]  C. Gerharz,et al.  Terminal differentiation and growth inhibition of a rat rhabdomyosarcoma cell line (BA-HAN-1C) in vitro after exposure to retinoic acid. , 1988, Cancer research.

[33]  G. Klein,et al.  Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Charon,et al.  The Bisindolylmaleimide GF 109203X Is a Potent and Selective Inhibitor of Protein Kinase C* , 2001 .

[35]  J. Prestle,et al.  Characterization of activators and inhibitors of protein kinase C mu. , 1995, European journal of biochemistry.

[36]  A. Cacace,et al.  Overexpression of protein kinase C beta 1 in the SW480 colon cancer cell line causes growth suppression. , 1995, Carcinogenesis.

[37]  H. Mischak,et al.  Assignment of the protein kinase C delta polypeptide gene (PRKCD) to human chromosome 3 and mouse chromosome 14. , 1994, Genomics.

[38]  M. Mareel Recent aspects of tumor invasiveness. , 1980, International review of experimental pathology.